#ASCOQLTY26
Dr. Sumanta Pal of @cityofhope.bsky.social and @ryannipp.bsky.social of OU Health Stephenson Cancer Center discuss high-impact research presented at #ASCOQLTY26 on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/4zg53kt
October 29, 2026 at 5:00 PM
🏆 Kian Tehranchi, MD, third-year hematology oncology clinical fellow at BIDMC, received a @conquercancer.bsky.social Merit Award at #ASCOQLTY26!

His abstract highlighted the positive impact of implementing an AI-enabled infusion scheduling workflow on clinical care in a high-volume cancer center.
October 19, 2026 at 7:45 PM
A huge ‘thank-you’ to all of our wonderful #ASCOQLTY26 Featured Voices for sharing their expertise on sessions and abstracts—and bringing so much joy and enthusiasm to the meeting! 💓

@ryannipp.bsky.social
October 17, 2026 at 7:05 PM
Dr. @crisbergerot.bsky.social and Dr. Angela Feraco chair a session examining systems-level care solutions & clinical models that personalize treatment for diverse pt populations, including AYAs and older adults at #ASCOQLTY26. https://bit.ly/4jOLWsE
October 17, 2026 at 6:29 PM
The last session has ended, and our time at #ASCOQLTY26 has come to a close.

Thank you to our incredible attendees, speakers, and patient advocates for coming together to share actionable insights, elevate care delivery, and improve outcomes for the cancer community. 🧡
October 17, 2026 at 7:40 PM
Happening now at #ASCOQLTY26: a “Quality Exchange” between this year’s Joseph Simone Quality Care Award winner Dr. Areej El-Jawahri and past recipients Dr. @ethanbasch.bsky.social and @drrobinyabroff.bsky.social. Session: https://bit.ly/4dyyjtL
October 17, 2026 at 4:37 PM
Can exercise reduce fatigue for patients receiving immunotherapy for cancer treatment? @jrgralow.bsky.social breaks down this latest abstract from @paulobergerot.bsky.social and colleagues presented at #ASCOQLTY26: https://bit.ly/4dHAk74
October 17, 2026 at 12:30 PM
What is the real-world role of AI in oncology? Moderated by Dr @fumikochino.bsky.social & Dr @anaikothari.bsky.social, experts are taking the stage at #ASCOQLTY26 to debate the future of artificial intelligence in cancer care balancing tech progress w vital pt-physician trust. https://bit.ly/4s2sR8I
October 17, 2026 at 2:44 PM
💡Our real-world analysis showed median time to consolidative #immunotherapy of 84 days from CRT start in Stage III #NSCLC (2018-2021). Uninsured, Medicaid, and tx at non-academic center associated w/ longer time to intiation
#ASCOQLTY26
@bidmc-cancercenter.bsky.social
@ascocancer.bsky.social
October 17, 2026 at 3:52 PM
Oncologists, patients, researchers debate live #ASCOQLTY26: what should role of AI be in cancer care? How/should it be regulated?

Is it helpful, & is there risk of over-regulating our way into another fax machine era in medicine? @andrewmibrahim.bsky.social @fumikochino.bsky.social
October 17, 2026 at 2:54 PM
New clinical insights from the #ASCOQLTY26 rapid oral session! 💡 Presenters are revealing how AI scribes support clinics, why screening adherence matters, and how tailored tools improve life post-treatment. Session: https://bit.ly/4rTeJOI
October 17, 2026 at 5:20 PM
J23 @fumikochino.bsky.social Figure 1 says it all - when health information goes viral it disseminates rapidly among people with cancer, & stays that way once it's out there #ASCOQLTY26
October 17, 2026 at 2:01 PM
Happening now at #ASCOQLTY26: Day 2 oral sessions are underway! 🗣️ Experts are on stage discussing the next frontier of oncology care, from debated AI workflows to innovative survivorship tools. https://bit.ly/4hEqHIO
October 17, 2026 at 12:42 PM
K7: Interviews on admin burden (ie the pain of asking cancer patients to coordinate their visits/tests during chemo). "The Maze," "The Flurry," "Tell Us Sooner," & "It Takes a Village" unfortunately feel like quotes straight from clinic. @bthomphd.bsky.social @drtessthompson.bsky.social #ASCOQLTY26
October 17, 2026 at 2:01 PM
If you’re in person with us at #ASCOQLTY26, join us this afternoon for two 15-minute demos of products that could help with your practice. Each demo will be followed by dedicated one-on-one Q&A time so you can learn more: https://bit.ly/4AQXHoO
October 17, 2026 at 2:15 PM
Day 2 of #ASCOQLTY26 starts now! 🍳 Fuel up with a complimentary hot breakfast from 7:20-8:20 AM (ET) and jump straight into this morning’s poster session.

☕ Grab your coffee, build a plate, and join the discussion: https://bit.ly/3TmqXCW
October 17, 2026 at 11:15 AM
‼️ #ASCOQLTY26 simultaneous publication by Baldwin-Medsker, et al.

Ambient Artificial Intelligent Scribes in Oncology: Impact on Clinician Experience and Documentation Burden

Read the article: https://bit.ly/4hKEtJX
October 17, 2026 at 5:00 PM
On #ASCOQLTY26 hot topic of AI use in oncology, live paper in JCO OP @jco-asco.bsky.social today on ambient scribes.

Huge range of use: some super-users, some not using at all. Overall, not reducing 'pajama time' but maybe helping some outliers.

Form your own opinion:
ascopubs.org/doi/pdf/10.1...
October 17, 2026 at 3:14 PM
And another thing I'm biased about, K3 & L11: two posters (the bias is that one is mine) both trying to better define time costs of cancer care in a way that's more helpful to patients. Strong quotes from pts in both that term "time toxicity" is unhelpful! #ASCOQLTY26 Kudos to Dr. Erin Bange!
October 17, 2026 at 2:01 PM
Just finished presenting these new findings at #ASCOQLTY26

Industry payments to oncologists are associated with aggressive end-of-life care for patients with cancer.
Physician payments & end-of-life tx:
-Slight ⬆️ aggressive EOL care among those who received payments
-However, is this a function of 3' centers seeing more patients at later lines of tx?
-Need to clarify research support vs personal $

#ASCOQLTY26
@thewonkologist.bsky.social @dusetzinas.bsky.social
October 16, 2026 at 7:20 PM
A few interesting #ASCOQLTY26 day 2 posters:
M13: Fezolinetant for hot flashes from breast cancer treatment. Funded by @bcrfcure.bsky.social, important because #breastcancer patients weren't included in original studies.

Significant ↓ in hot flash frequency compared to placebo!
October 17, 2026 at 2:01 PM
M1: @swog.org's Pitch the PAC (Patient Advocacy Committee) setup. I am a beneficiary of this program - getting to workshop ideas with an entire committee of dedicated advocates is invaluable. More cooperative groups should do this! #ASCOQLTY26 @ammercurio.bsky.social @barbarasegarra.bsky.social
October 17, 2026 at 2:01 PM
Learning about “Delivering Value in Everyday Oncology Care” right now at #ASCOQLTY26 in a session chaired by Dr. Ryan Huey and Dr. Hari Nathan: https://bit.ly/4jdqFc4
October 16, 2026 at 7:15 PM
My $0.02 on the❓of "is AI destroying the doctor/patient relationship": No, people not feeling they can trust their doctors is. (For both true & misinfo reasons). It's our role to be trustworthy 1-on-1 with our pts.

Curious to hear thoughts from others in oncology.

#ASCOQLTY26
Oncologists, patients, researchers debate live #ASCOQLTY26: what should role of AI be in cancer care? How/should it be regulated?

Is it helpful, & is there risk of over-regulating our way into another fax machine era in medicine? @andrewmibrahim.bsky.social @fumikochino.bsky.social
October 17, 2026 at 3:03 PM
E16: I'm biased, but I think this is one of the most exciting innovations coming in cancer care. What if we could decrease waste and save people money at the same time? Promise to improve not just cost of treating cancer but cancer control itself. #ASCOQLTY26 @emilymackler.bsky.social
October 17, 2026 at 2:01 PM